Population-based input function and image-derived input function for [11C](R)-rolipram PET imaging: Methodology, validation and application to the study of major depressive disorder

NeuroImage

Volumn 63, Issue 3, 2012, Pages 1532-1541

  Zanotti Fregonara, Paolo ^a   Hines, Christina S ^a   Zoghbi, Sami S ^a   Liow, Jeih San ^a   Zhang, Yi ^a   Pike, Victor W ^a   Drevets, Wayne C ^b   Mallinger, Alan G ^a   Zarate, Carlos A ^a   Fujita, Masahiro ^a   Innis, Robert B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

11C (R) rolipram; Image derived input function; Major depressive disorder; Population based input function

Indexed keywords

CARBON 11; ROLIPRAM;

ADULT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTICLE; BODY SURFACE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DERIVED INPUT FUNCTION; INTERNAL CAROTID ARTERY; LEAN BODY WEIGHT; MAJOR DEPRESSION; MALE; POPULATION BASED INPUT FUNCTION; POPULATION RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; TEST RETEST RELIABILITY; VALIDATION STUDY; VENOUS BLOOD; VOLUNTEER;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN; CARBON RADIOISOTOPES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; ROLIPRAM;

EID: 84866184249     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.08.007     Document Type: Article

References (54)

1. Abi-Dargham A., Laruelle M., Krystal J., D'Souza C., Zoghbi S., Baldwin R.M., Seibyl J., Mawlawi O., de Erasquin G., Charney D., Innis R.B. No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia. Neuropsychopharmacology 1999, 20:650-661.
2. Berradja K., Boughanmi N., Bentourkia M. Kinetic modeling of brain FDG data with input function derived from images by independent component analysis. IEEE Nucl Sci Symp Conf Rec 2009, 2920-2923.
3. Bloomfield P.M., Spinks T.J., Reed J., Schnorr L., Westrip A.M., Livieratos L., Fulton R., Jones T. The design and implementation of a motion correction scheme for neurological PET. Phys. Med. Biol. 2003, 48:959-978.
4. Boyd E. The growth of the surface area of the human body. Monograph Series 1935, 10:53-60. University of Minnesota Press, Minneapolis.
5. Carson R.E., Barker W.C., Liow J.-S., Yao R., Thada S., Zhao Y., Iano-Fletcher A., Lenox M., Johnson C.A. List-mode reconstruction for the HRRT. J. Nucl. Med. 2004, 45:105P.
6. Chen K., Bandy D., Reiman E., Huang S.C., Lawson M., Feng D., Yun L.S., Palant A. Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J. Cereb. Blood Flow Metab. 1998, 18:716-723.
7. Cheymol G. Clinical pharmacokinetics of drugs in obesity - an update. Clin. Pharmacokinet. 1993, 25:103-114.
8. Chiou W.L. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (part I). Clin. Pharmacokinet. 1989, 17:175-199.
9. Chiou W.L. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (part II). Clin. Pharmacokinet. 1989, 17:275-290.
10. Cook G.J., Lodge M.A., Marsden P.K., Dynes A., Fogelman I. Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur. J. Nucl. Med. 1999, 26:1424-1429.
11. DuBois D., DuBois E. A formula to estimate the approximate surface area if height and weight be known. Arch. Intern. Med. 1916, 17:863-871.
12. Eberl S., Anayat A.R., Fulton R.R., Hooper P.K., Fulham M.J. Evaluation of two population-based input functions for quantitative neurological FDG PET studies. Eur. J. Nucl. Med. 1997, 24:299-304.
13. Everett B.A., Oquendo M.A., Abi-Dargham A., Nobler M.S., Devanand D.P., Lisanby S.H., Mann J.J., Parsey R.V. Safety of radial arterial catheterization in PET research subjects. J. Nucl. Med. 2009, 50:1742.
14. 11C]rolipram-PET. NeuroImage 2005, 26:1201-1210.
15. Fujita M., Hines C.S., Zoghbi S.S., Mallinger A.G., Dickstein L.P., Liow J.S., Zhang Y., Pike V.W., Drevets W.C., Innis R.B., Zarate C.A. Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram PET in major depressive disorder. Biological Psychiatry 2012, Jun 5 (Epub ahead of print).
16. Gehan E.A., George S.L. Estimation of human body surface area from height and weight. Cancer Chemother. Rep. 1970, 54:225-235.
17. Greuter H., Lubberink M., Hendrikse N.H., Van der Veldt A.A., Wong Y., Schuit R., Windhorst A.D., Boellaard R., Lammertsma A.A. Venous versus arterial blood samples for plasma input pharmacokinetic analysis of different radiotracer PET studies. SNM conference proceedings 2011.
18. Hahn A., Nics L., Baldinger P., Ungersböck J., Dolliner P., Frey R., Birkfellner W., Mitterhauser M., Wadsak W., Karanikas G., Kasper S., Lanzenberger R. Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling. Neuroimage 2012, 62:199-206.
19. Haycock G.B., Schwartz G.J., Wisotsky D.H. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J. Pediatr. 1978, 93:62-66.
20. Hume R. Prediction of lean body mass from height and weight. J. Clin. Pathol. 1966, 19:389-391.
21. Iida H., Itoh H., Bloomfield P., Munaka M., Higano S., Murakami M., Inugami A., Eberl S., Aizawa Y., Kanno I., Uemura K. A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur. J. Nucl. Med. 1994, 21:1072-1084.
22. Ito H., Koyama M., Goto R., Kawashima R., Ono S., Atsumi H., Ishii K., Fukuda H. Cerebral blood flow measurement with iodine-123-IMP SPECT, calibrated standard input function and venous blood sampling. J. Nucl. Med. 1995, 36:2339-2342.
23. James W. Research on obesity. D.H.S.S./M.R.C. Group report 1976, 16. Her Majesty's Stationery Office.
24. Jouvie C., de Gavriloff S., Santiago Ribeiro M.J., Gaura V., Remy P., Zanotti-Fregonara P., Maroy R. Biomedical Imaging: From Nano to Macro. 2011 IEEE International Symposium on. 2011, 1758-1761.
25. Kimura Y., Simeon F.G., Zoghbi S.S., Zhang Y., Hatazawa J., Pike V.W., Innis R.B., Fujita M. Quantification of metabotropic glutamate subtype 5 receptors in the brain by an equilibrium method using (18)F-SP203. NeuroImage 2012, 59:2124-2130.
26. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab. Rev. 2009, 41:67-76.
27. Meyer P.T., Circiumaru V., Cardi C.A., Thomas D.H., Bal H., Acton P.D. Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function. Eur. J. Nucl. Med. Mol. Imaging 2006, 33:948-954.
28. Morgan D.J., Bray K.M. Lean body-mass as a predictor of drug-dosage - implications for drug-therapy. Clin. Pharmacokinet. 1994, 26:292-307.
29. Mosteller R.D. Simplified calculation of body-surface area. N. Engl. J. Med. 1987, 317:1098.
30. Mourik J.E., Lubberink M., Klumpers U.M., Comans E.F., Lammertsma A.A., Boellaard R. Partial volume corrected image derived input functions for dynamic PET brain studies: methodology and validation for [11C]flumazenil. NeuroImage 2008, 39:1041-1050.
31. Mourik J.E., van Velden F.H., Lubberink M., Kloet R.W., van Berckel B.N., Lammertsma A.A., Boellaard R. Image derived input functions for dynamic High Resolution Research Tomograph PET brain studies. NeuroImage 2008, 43:676-686.
32. Naganawa M., Kimura Y., Ishii K., Oda K., Ishiwata K., Matani A. Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis. IEEE Trans. Biomed. Eng. 2005, 52:201-210.
33. Ogden R.T., Zanderigo F., Choy S., Mann J.J., Parsey R.V. Simultaneous estimation of input functions: an empirical study. J. Cereb. Blood Flow Metab. 2010, 30:816-826.
34. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method. Ann. Neurol. 1979, 6:371-388.
35. 14C]iodoantipyrine. Am. J. Physiol. 1990, 258:H1585-H1598. (Heart Circ. Physiol. 27).
36. Sawyer M., Ratain M.J. Body surface area as a determinant of pharmacokinetics and drug dosing. Invest. New Drugs 2001, 19:171-177.
37. Seike Y., Hashikawa K., Oku N., Moriwaki H., Yamamoto H., Fukuchi K., Watanabe Y., Matsumoto M., Hori M., Nishimura T. Evaluation of the use of a standard input function for compartment analysis of [123I]iomazenil data: factors influencing the quantitative results. Ann. Nucl. Med. 2004, 18:563-572.
38. Shiozaki T., Sadato N., Senda M., Ishii K., Tsuchida T., Yonekura Y., Fukuda H., Konishi J. Noninvasive estimation of FDG input function for quantification of cerebral metabolic rate of glucose: optimization and multicenter evaluation. J. Nucl. Med. 2000, 41:1612-1618.
39. Su K.H., Wu L.C., Liu R.S., Wang S.J., Chen J.C. Quantification method in [18F]fluorodeoxyglucose brain positron emission tomography using independent component analysis. Nucl. Med. Commun. 2005, 26:995-1004.
40. Takagi S., Takahashi W., Shinohara Y., Yasuda S., Ide M., Shohtsu A., Seio T. Quantitative PET cerebral glucose metabolism estimates using a single non-arterialized venous-blood sample. Ann. Nucl. Med. 2004, 18:297-302.
41. Takikawa S., Dhawan V., Spetsieris P., Robeson W., Chaly T., Dahl R., Margouleff D., Eidelberg D. Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993, 188:131-136.
42. Takikawa S., Dhawan V., Chaly T., Robeson W., Dahl R., Zanzi I., Mandel F., Spetsieris P., Eidelberg D. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. J. Nucl. Med. 1994, 35:955-963.
43. Tikuisis P., Meunier P., Jubenville C.E. Human body surface area: measurement and prediction using three dimensional body scans. Eur. J. Appl. Physiol. 2001, 85:264-271.
44. Tsuchida T., Sadato N., Yonekura Y., Nakamura S., Takahashi N., Sugimoto K., Waki A., Yamamoto K., Hayashi N., Ishii Y. Noninvasive measurement of cerebral metabolic rate of glucose using standardized input function. J. Nucl. Med. 1999, 40:1441-1445.
45. Vriens D., de Geus-Oei L.F., Oyen W.J., Visser E.P. A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment. J. Nucl. Med. 2009, 50:1933-1939.
46. Wakita K., Imahori Y., Ido T., Fujii R., Horii H., Shimizu M., Nakajima S., Mineura K., Nakamura T., Kanatsuna T. Simplification for measuring input function of FDG PET: investigation of 1-point blood sampling method. J. Nucl. Med. 2000, 41:1484-1490.
47. Yu C.Y., Lin C.H., Yang Y.H. Human body surface area database and estimation formula. Burns 2010, 36:616-629.
48. Zanotti-Fregonara P., Fadaili el M., Maroy R., Comtat C., Souloumiac A., Jan S., Ribeiro M.J., Gaura V., Bar-Hen A., Trebossen R. Comparison of eight methods for the estimation of the image-derived input function in dynamic [(18)F]-FDG PET human brain studies. J. Cereb. Blood Flow Metab. 2009, 29:1825-1835.
49. Zanotti-Fregonara P., Liow J.S., Fujita M., Dusch E., Zoghbi S.S., Luong E., Boellaard R., Pike V.W., Comtat C., Innis R.B. Image-derived input function for human brain using high resolution PET imaging with [C](R)-rolipram and [C]PBR28. PLoS One 2011, 6:e17056.
50. Zanotti-Fregonara P., Zoghbi S.S., Liow J.S., Luong E., Boellaard R., Gladding R.L., Pike V.W., Innis R.B., Fujita M. Kinetic analysis in human brain of [11C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: a retest study and use of an image-derived input function. NeuroImage 2011, 54:1903-1909.
51. Zanotti-Fregonara P., Chen K., Liow J.S., Fujita M., Innis R.B. Image-derived input function for brain PET studies: many challenges and few opportunities. J. Cereb. Blood Flow Metab. 2011, 31:1986-1998.
52. Zanotti-Fregonara P., Liow J.S., Comtat C., Zoghbi S.S., Zhang Y., Pike V.W., Fujita M., Innis R.B. Image-derived input function in PET brain studies: blood-based methods are resistant to motion artifacts. Nucl. Med. Commun. 2012, 33:982-989.
53. Zanotti-Fregonara P., Maroy R., Peyronneau M.A., Trebossen R., Bottlaender M. Minimally invasive input function for 2-(18)F-fluoro-A-85380 brain PET studies. Eur. J. Nucl. Med. Mol. Imaging 2012, 39:651-659.
54. 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements. J. Nucl. Med. 2006, 47:520-527.